News Search Results
Jun 09, 2026, 11:30 ET Beckman Foundation Announces 2026 Beckman Young Investigator Awardees
nanoscience: new tools for coral reef resilienceMonica Neugebauer, PhDUniversity of Wisconsin-MadisonMerging synthetic biology and organometallic chemistry to create new catalystsSamuel Root, PhDCase Western Reserve University*Imaging
More news about: Arnold and Mabel Beckman Foundation
Jun 05, 2026, 10:00 ET Eratrectinib, the next-generation TRK inhibitor independently developed by Vcare PharmaTech, has received marketing approval
R&D platforms have been officially accredited as Nanjing Key Laboratory for AI-Assisted Drug Design and Nanjing Engineering Research Center for Synthetic Biology & Flow Chemistry; its AI-directed site-specific enzyme mutation technology has been recognized as Advanced Cleaner Production Technology by
More news about: Vcare PharmaTech
Jun 05, 2026, 08:35 ET Pinnacle Food Group Limited Appoints Dr. Yunhao Chen as Chief Financial Officer
agriculture and bio-engineering. The Company's "Dual-Engine" strategy integrates Farming-as-a-Service solutions with precision fermentation and synthetic biology platforms to support the development of efficient and sustainable food systems. For more information, please visit the Company's website at
More news about: Pinnacle Food Group Limited
Jun 04, 2026, 10:17 ET America's Top Young Innovators to Showcase PhD-Level Research and Patent-Pending Inventions at the 2026 National STEM Festival®
interactive 3D digital cadaver on the Anatomage TableHold NASA's STELLA satellite-science instrument in your handStep inside a mobile synthetic-biology labDesign, build, and test paper airplanes to see how far and accurately they can fly with COSI and Boeing"What makes the
More news about: EXPLR
Jun 04, 2026, 09:35 ET Global Ergothioneine Market Poised for Accelerated Growth as Scientific Validation and Synthetic Biology Reshape Industry Dynamics
transitioning from a niche antioxidant ingredient into a scalable, science-backed platform for health and wellness innovation. Driven by advances in synthetic biology, expanding clinical research, and growing consumer demand for evidence-based longevity solutions, the industry is entering a new phase of commercial
More news about: Frost & Sullivan
Jun 04, 2026, 09:35 ET Global Ergothioneine Market Poised for Accelerated Growth as Scientific Validation and Synthetic Biology Reshape Industry Dynamics
transitioning from a niche antioxidant ingredient into a scalable, science-backed platform for health and wellness innovation. Driven by advances in synthetic biology, expanding clinical research, and growing consumer demand for evidence-based longevity solutions, the industry is entering a new phase of commercial
More news about: Frost & Sullivan
Jun 02, 2026, 12:00 ET Rise Therapeutics Completes Enrollment in Four-Week Dose Expansion Cohort for the R-2487 Rheumatoid Arthritis Clinical Trial
treatment-related limitations, highlighting the opportunity for the novel R-2487 treatment approach.About R-2487R-2487 is a synthetic biology-based immunotherapy designed to address underlying immune dysfunction in autoimmune diseases. The therapy works by inducing bystander immune tolerance
More news about: Rise Therapeutics
May 28, 2026, 09:00 ET China-US Dual Filing Success: Porton Advanced's End-to-End Bacterial Vector CDMO Solution Accelerates NMPA Approval of Salvectors' Innovative Oncolytic Bacteria Therapy
China, marking the beginning of a new chapter in global clinical development. This milestone not only recognizes Salvectors' proprietary synthetic biology platform but also validates the strong collaboration between Salvectors and Porton Advanced. From the U.S. to
More news about: Porton Advanced
May 26, 2026, 12:33 ET Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Launch ADME-One™: a High-Throughput ADME Platform That Brings Pharmacokinetic Projection Earlier in Drug Discovery
business opportunities, including with respect to our solutions and tools offerings, (iv) the risk of downturns in demand for products using synthetic biology, (v) the uncertainty regarding the demand for passive monitoring programs and biosecurity services, (vi) changes to the biosecurity industry,
More news about: Inductive Bio, Inc.
May 26, 2026, 11:00 ET bitBiome Closes Oversubscribed Seed Extension Round
probabilities of success, continue to expand our global presence, and drive partnerships across industrial biotech, pharma and life science, synthetic biology and advanced biomanufacturing."As biology becomes increasingly data-driven, investors are placing greater emphasis on platforms with differentiated
More news about: bitBiome
May 14, 2026, 08:00 ET Rice Biotech Launch Pad to Sponsor 2nd Edition of the BioElectronic Therapeutics (BETx) Event hosted by the Rice Global Paris Center in June
Capital Strategies for Scaling Bioelectronics InnovationNext Generation Neuroelectronic InterfacesThe Intersection of Synthetic Biology and BioelectronicsHybrid Bioelectronic Systems: Integrating Living Materials with DevicesAdvanced Bioelectronic Sensing: From
More news about: Rice University
May 13, 2026, 08:04 ET ERS Genomics and Aurigene Sign CRISPR/Cas9 License Agreement to Advance Precision Genome Editing in Drug Discovery
cell lines and animal models for drug screening, bioproduction of antibodies and therapeutic proteins, animal and agricultural biotechnology, synthetic biology, including production of enzymes, food ingredients, and bio-based chemicals.Current ERS licensees include GSK, Merck, Bayer, Thermo Fisher
More news about: ERS Genomics
May 12, 2026, 05:55 ET ATUM's New Lock-In™ Platform Solves Bispecific Mispairing
research organization (CRO) providing services for gene design, protein engineering, and cell line development. By combining machine learning, synthetic biology, and proprietary expression technologies, ATUM helps partners worldwide transform digital sequences into clinical reality. ATUM is headquartered
More news about: ATUM
May 11, 2026, 13:33 ET DNA Synthesis Market to Reach $30.4 billion, Globally, by 2035 at 18.2% CAGR: Allied Market Research
strong adoption across pharmaceutical and biotechnology companies, academic and research institutes, contract research organizations (CROs), and synthetic biology firms due to its critical role in enabling advanced genetic research and biopharmaceutical development.PORTLAND,
More news about: Allied Market Research
May 11, 2026, 12:41 ET DNA Polymerase Market to Reach USD 725.8 Million by 2035 as Molecular Diagnostics and High-Fidelity Enzymes Accelerate Precision Genomics
become foundational tools in modern genomics, enabling critical applications such as PCR-based diagnostics, gene sequencing, forensic analysis, synthetic biology, and gene-editing workflows. The increasing prevalence of infectious diseases, genetic disorders, and cancer is significantly amplifying demand
More news about: Future Market Insights
May 11, 2026, 12:08 ET muShanghai Opens: 800 Global Builders Converge in Shanghai for a 28-Day Pop-Up City Experiment
cryptographers.BioTech & Longevity Week (May 18–22): Led by a Yale-trained computational biologist, this week focuses on AI drug discovery and synthetic biology. Highlights include XtalPi's AI pharma insights and a CGM dietary experiment. The week culminates in BioBloom, a hackathon tackling real-world
More news about: The Mu
May 07, 2026, 16:05 ET Ginkgo Bioworks Reports First Quarter 2026 Financial Results, Completes Divestiture of Biosecurity and Continues to Scale Autonomous Lab
business opportunities, including with respect to our solutions and tools offerings, (iv) the risk of downturns in demand for products using synthetic biology, (v) the uncertainty regarding the demand for passive monitoring programs and biosecurity services, (vi) changes to the biosecurity industry,
More news about: Ginkgo Bioworks
May 06, 2026, 03:00 ET Ribbon Bio Launches Cell-Free MiroSynth DNA and New In-Lab Cell-Free DNA Production Kit
synthesis of complex DNA away from a centralized, capacity‑limited service into a more accessible, flexible, and scalable tool for the biopharma and synthetic biology communities.Built Without BacteriaTraditional DNA manufacturing is heavily constrained by its underlying biological
More news about: Ribbon Bio
May 05, 2026, 15:12 ET Molecular Instruments & Empire Genomics Launch NISH Powered by HCR™ Pro: The Largest Ready-to-Use, Fully Automated ISH Library, Exclusively Available Worldwide on NeoPATH Pro
develops and synthesizes molecular kits powered by the breakthrough HCR™ imaging platform for applications in academic research, drug discovery, and synthetic biology.About Empire GenomicsEmpire Genomics (a Biocare Medical company) is the first choice in FISH probes for clinical and research,
More news about: Empire Genomics
Apr 29, 2026, 05:00 ET Biohub Launches the Virtual Biology Initiative to Galvanize a Global Effort to Create the Open Data Foundation for AI-Accelerated Biology
Sapiens multi-organ cell atlas, and a range of integrated grant programs across imaging and instrumentation, spatial molecular biology, and synthetic biology.Efforts within Biohub and across the scientific communityA much larger global effort will be needed to reach the necessary
More news about: Biohub
Apr 28, 2026, 10:18 ET From gut to brain: NUS scientists engineer bacteria to treat severe liver-related brain dysfunction
National University of Singapore (NUS), led by Professor Matthew Chang from the NUS Synthetic Biology for Clinical and Technological Innovation (SynCTI) has recently achieved a major breakthrough on this front.The researchers, who are
More news about: National University of Singapore
Apr 21, 2026, 08:46 ET BiomEdit Secures Foundational Patents for Engineered Probiotic Platform Positioned to Redefine Animal Health
therapeutics.About BiomEditBiomEdit is an animal health biotechnology company leveraging the power of the microbiome and synthetic biology to develop next-generation solutions for livestock and pet health. Founded in 2022, BiomEdit is backed by leading investors including Anterra
More news about: BiomEdit
Apr 21, 2026, 06:30 ET Flagship Pioneering Launches Serif Biomedicines to Establish Modified DNA as a New Biotechnology
biotechnology. Founded in 2021 within Flagship Labs, the innovation foundry of Flagship Pioneering, Serif integrates nucleic acid chemistry, synthetic biology, delivery science, and artificial intelligence to enable programmable, scalable, durable, and redosable DNA medicines. The company's initial focus
More news about: Flagship Pioneering
Apr 20, 2026, 08:30 ET Pinnacle Food Group Limited Announces Entry Into a Non-Binding MOU to Explore Establishing an Open Yeast Platform Hub in Hong Kong
in yeast, originally established by Dr. Scott Pownall in 2021. The current library contains hundreds of valuable DNA assembly parts to support synthetic biology research and biotechnology in yeast. The second part is the Open Yeast Strain Bank, an open-access, growing library of yeast strains made available
More news about: Pinnacle Food Group Limited
Apr 16, 2026, 06:16 ET ATUM Appoints Industry Veteran Gavin Barnard, Ph.D., as Chief Scientific Officer
research organization that provides services for gene design, protein engineering, and cell line development. By combining machine learning, synthetic biology, and proprietary expression technologies, ATUM helps partners worldwide transform digital sequences into clinical reality. ATUM is headquartered
More news about: ATUM